General Information of the Compound
| Compound ID |
CP0046618
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-(3-chlorophenyl)piperazine
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-(m-chlorophenyl)piperazine
m-chlorophenylpiperazine
meta chlorophenyl piperazine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C10H13ClN2
|
||||||||||||||||||
| Molecular Weight |
196.681
|
||||||||||||||||||
| Canonical SMILES |
Clc1cccc(c1)N1CCNCC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C10H13ClN2/c11-9-2-1-3-10(8-9)13-6-4-12-5-7-13/h1-3,8,12H,4-7H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
VHFVKMTVMIZMIK-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
6640-24-0
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Cell-based Assay
Protein ID: PT01019, 5-hydroxytryptamine receptor 2B
Cell-based Assay
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C
Cell-based Assay
Protein ID: PT01746, 5-hydroxytryptamine receptor 7
Clinical Information about the Compound
Drug 1 ( m-chlorophenylpiperazine )
| Drug Name | m-chlorophenylpiperazine | ||
|---|---|---|---|
| Target(s) | |||